Updated Jul 16, 2026
Gavel Steve is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $50K.
Steve Gavel is the Chief Commercial Officer at Cabaletta Bio, Inc., a biotechnology company focused on engineered T cell therapies. He has been involved in the company's efforts to develop treatments for B cell-mediated autoimmune diseases.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-21 | CABA | Cabaletta Bio, Inc. | P — Open-market purchase | 22.2K | $2.27 | $50K |
Steve Gavel is the Chief Commercial Officer at Cabaletta Bio, Inc., a biotechnology company focused on engineered T cell therapies. He has been involved in the company's efforts to develop treatments for B cell-mediated autoimmune diseases.…
Recorded transactions: 1 open-market purchases ($50K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Gavel Steve profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.